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Abstract: This study examined the role of endocannabinoid signaling in
stress-induced reinstatement of cocaine seeking and explored the interaction
between noradrenergic and endocannabinergic systems in the process. A
well-validated preclinical model for human relapse, the rodent conditioned
place preference assay was used. Cocaine-induced place preference was
established in C57BL/6 mice using injections of 15 mg/kg cocaine. Following
extinction of preference for the cocaine-paired environment, reinstatement of
place preference was determined following 6 min of swim stress, or cocaine
injection (15 mg/kg, i.p.). The role of endocannabinoid signaling was studied
using the cannabinoid antagonist AM-251 (3 mg/kg, i.p.). Another cohort of
mice was tested for reinstatement following administration of the cannabinoid
agonist CP 55,940 (10, 20 or 40 μg/kg, i.p.). The alpha-2 adrenergic
antagonist BRL-44408 (5 mg/kg, i.p.) with or without CP 55,940 (20 μg/kg)
was administered to a third group of mice. We found that: 1) AM-251 blocked
forced swim-induced but not cocaine-induced reinstatement of cocaineseeking behavior; 2) the cannabinoid agonist CP 55,940 did not reinstate
cocaine-seeking behavior when administered alone but did synergize with a
non-reinstating dose of the alpha-2 adrenergic antagonist BRL-44408 to
cause reinstatement. These results are consistent with the hypothesis that
stress exposure triggers the endogenous activation of CB1 receptors and that
activation of the endocannabinoid system is required for the stress-induced
relapse of the mice to cocaine seeking. Further, the data suggests that the
endocannabinoid system interacts with noradrenergic mechanisms to
influence stress-induced reinstatement of cocaine-seeking behavior.
Keywords: cannabinoids, cocaine, norepinephrine, relapse, stress,
conditioned place preference

Cocaine abuse and dependence are important problems with
significant psychosocial, medical and financial implications. One of the
more troubling aspects of addiction is the persistent vulnerability to
relapse to drug use that continues even after long periods of
abstinence. Although relapse can be induced by re-exposure to
cocaine, drug-associated cues or stress (Childress et al., 1992; See et
al., 1999; Shaham et al., 2000; Stewart, 2000; Kalivas and McFarland,
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2003), exposure to stress is particularly injurious given its
inescapability. The investigation of neurobiological mechanisms at the
intersection of motivated behavior and stress could prove fruitful in the
search for potential treatments for stress-induced drug relapse. The
endocannabinoid system (ECS), including the cannabinoid receptors
(CB1 and CB2), endocannabinoids (N-arachidonylethanolamine and 2arachidonoylglycerol) and enzymes and transporters which control
synaptic concentrations of endocannabinoids, are attractive targets in
this regard.
The preclinical investigation of relapse involves the use of
reinstatement protocols in which various stimuli are tested for their
ability to re-establish extinguished drug-seeking behavior (Shaham
2003). Conditioned place preference is commonly used to study
reinstatement in mice. Using this method, cocaine-induced conditioned
place preference becomes extinguished with repeated drug-free
exposure to the cocaine-paired environment. The ability of various
stimuli to re-establish the cocaine preference is then tested
(Tzschentke, 2007). Using this protocol, priming injections of cocaine
and a variety of stressors have been shown to produce reinstatement
(Itzhak and Martin, 2002; Kreibich and Blendy, 2004; Ribeiro Do Couto
et al., 2006; Tzchentke, 2007; Orsini, et al., 2008; Redila and
Chavkin, 2008; Mantsch et al., 2010).
There is strong evidence that the ECS is activated in multiple
brain regions involved in addiction by stress exposure (Di et al, 2005;
Gorzalka et al., 2008; Patel and Hillard, 2008; Rademacher et al,
2008; Hill et al., 2009). It is hypothesized that the result of this
activation in most brain regions is to oppose the effects of stress (Cota
2008; Gorzalka et al., 2008; Hill et al., 2010). For example, CB1
receptor knock out animals have increased basal and stress-induced
HPA activity, (Barna et al., 2004; Cota et al., 2007), CB1 antagonists
increase basal and stress induced glucocorticoid secretion (Manzanares
et al., 1999; Patel et al., 2004; Wade et al., 2006), and CB1 agonists
and clearance inhibitors reduce stress-induced glucocorticoid secretion
(Patel et al., 2004).
Central noradrenergic systems also play an important role in the
physiological response to stress (Abercrombie et al., 1988; Tanaka et
al., 1991; Finlay et al., 1995) and interactions between the
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noradrenergic system and cocaine are well documented (Sofuoglu and
Sewell, 2009). Repeated cocaine exposure produces long-lasting
adaptations within central noradrenergic systems that can lead to
enhanced noradrenergic responsiveness during stress (Belej, et al
1996; Macey, et al 2003; Baumann, et al 2004; Beveridge, et al 2005;
Lanteri, et al 2008) and norepinephrine (NE) release is required for
stress-induced drug reinstatement using both rat self-administration
models (Erb et al., 2000; Leri et al., 2002) and mouse conditioned
place preference protocols (Mantsch et al., 2010).
The ECS has a well-established role in enhancing the
motivational effects and promoting drug seeking and relapse behavior
of alcohol, nicotine, opioids and marijuana (Tanda and Goldberg,
2003; Lupica et al., 2004; Gardner, 2005; Cohen et al., 2005). Studies
of the role of the ECS in the rewarding aspects of cocaine have shown
inconsistent effects (Fattore et al., 1999; Soria et al., 2005; Xi et al.,
2008; Wiskerke et al., 2008; Orio et al., 2009) but the ECS seems to
play an important role in relapse behavior. DeVries et al., (2001)
found that a cannabinoid agonist reinstated cocaine seeking in rats
that had been conditioned and extinguished in a self-administration
paradigm and that a cannabinoid antagonist prevented cocaine- and
cue- but not stress- induced reinstatement of cocaine seeking.
Cannabinoid mechanisms were also implicated in cocaine-primed
reinstatement in rats (Xi et al., 2006; Filip et al., 2006). In mice,
however, cue-induced but not cocaine-induced reinstatement was
blocked by a cannabinoid antagonist (Ward et al., 2009). Surprisingly,
given the well-established link between the ECS and stress, there has
been only one investigation of the role of stress-induced cocaine
reinstatement (De Vries et al., 2001) and there have been no studies
on the interaction between the endocannabinoid and noradrenergic
systems in stress-induced cocaine relapse.
The purpose of this study was to examine the role of the ECS in
cocaine- and stress-induced relapse of cocaine seeking behavior and
its interaction with noradrenergic mechanisms in mice using a
conditioned place preference reinstatement approach.
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Experimental Procedures
Animals
Male C57BL/6 mice, 8-9 weeks old, were purchased from Harlan
(Indianapolis, IN). The mice were housed singly in a temperature- and
humidity-controlled, AAALAC- accredited animal facility under a 12
h/12 h light/dark cycle (lights on at 7:00 AM) and had access to food
and water at all times, except when in the experimental chambers.
The animals were acclimatized for one week in the animal care facility
before use in the studies. All experiments had been reviewed and
approved by the Institutional Animal Care and Use Committee and
were carried out in accordance with the Guide for the Care and Use of
Laboratory Animals.

Drugs
Cocaine HCl was acquired from the National Institute on Drug
Abuse (Bethesda, MD) through the NIDA Drug Supply Program. CP
55,940 and AM-251 were purchased from Sigma-Aldrich (St. Louis,
MO) and BRL-44408 maleate was acquired from Tocris Bioscience
(Minneapolis, MN). Cocaine and BRL-44408 were dissolved in saline
(0.9% NaCl solution) and CP 55,940 and AM-251 were dissolved in a
1:1:18 ratio of ethanol, Cremophor EL (Sigma-Aldrich), and saline.
Cocaine and BRL-44408 solutions were administered i.p. in a volume
of 0.1 ml/25 g body weight. CP 55,940 and AM-251 were administered
i.p. in a volume of 0.1 ml/10 g body weight. Pretreatment times for CP
55,940, BRL-44408 and AM-251 were 30 min.

Equipment
Behavioral testing was conducted using six ENV-3013 threechambered mouse place preference chambers from Med-Associates,
Inc (St. Albans, VT). Two 46.5 × 12.7 × 12.7 cm side compartments
were each connected to a 7.2 cm × 12.7 cm gray-colored center
compartment. One side compartment had white walls and a stainless
steel mesh floor and the other side compartment had black walls and a
stainless steel grid rod floor. The clear tops of the compartments were
hinged to permit placement and removal of the mice. Room ceiling
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lights were turned on and, to balance unconditioned side preference,
the black compartments were illuminated with additional suspended
lights, providing a total illumination of approximately 300 lux.
Automated data collection was accomplished using photobeams (6
beams for the white and black test areas and 2 beams for the center
gray area) which were evenly spaced across the length of the chamber
and interfaced with a computer containing Med-PC software.

Cocaine-Induced Conditioned Place Preference
Cocaine-induced conditioned place preference was established
using an unbiased design in which one of the side compartments was
randomly designated as the cocaine compartment and the other as the
saline compartment. On the first day of the procedure, mice were
placed into the center compartment of the chamber and provided free
access to both side compartments for 30 minutes in the absence of
saline or cocaine pretreatment to determine pre-conditioning
preference. During the 8-day conditioning phase of the experiment,
mice received cocaine (15 mg/kg, ip) and saline injections on
alternating days after which time they were confined to the randomly
designated treatment-appropriate compartment for 30 minutes. After
the final conditioning session, mice were tested for the expression
cocaine-induced conditioned place preference by once again placing
them into the center compartment of the chamber and providing them
with free access to the side compartments for 30 minutes. Conditioned
place preference was defined as the change in time spent in the
cocaine-paired compartment after conditioning compared to the initial
pre-conditioning session. The 15 mg/kg cocaine dose was selected
based on previous results (Mantsch et al., 2010).

Extinction
Following conditioning, daily extinction training was conducted.
During the extinction sessions, mice were placed into the center
compartment and allowed free access to the side compartments for 30
min. Mice underwent daily extinction training until the conditioned
place preference for the cocaine-paired compartment during the
session was reduced by at least 50%.
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Reinstatement Testing
The reinstatement sessions were identical to the extinction
sessions except that mice received exposure to stressors and/or drug
injections prior to the session. Reinstatement was defined as the
increase in time spent in the cocaine-paired compartment on the test
day (reinstatement day) compared to the time spent on the cocainepaired compartment on the previous day (extinction day). Mice were
tested more than once for reinstatement, receiving all treatments
within a given experiment. The stressors and/or drugs were given in
counter-balanced order to avoid potential sequence effects.
Reinstatement sessions were separated by additional extinction
sessions. Mice were required to reach the extinction criterion once
again before the next reinstatement test was conducted.

Forced Swim Stress-Induced Reinstatement Testing
Forced swim stress (FS)-induced reinstatement was examined
by placing the mice into a 30 cm h × 20 cm d cylindrical polypropylene
container filled with water (20-25° C) for 6 min, 24 min after
pretreatment with drug or respective vehicles. Following FS, mice were
placed back into their home cages for 1-2 min prior to introduction into
the center compartment of the place conditioning chamber for
reinstatement testing.

Cocaine-Induced Reinstatement Testing
Reinstatement induced by a cocaine priming injection was
tested in mice by injection of 15 mg/kg dose of cocaine i.p.
immediately before placement into the center compartment of the
place conditioning chamber for reinstatement testing.

Effect of the CB1 Receptor Antagonist, AM-251, on
Stress- and Cocaine-Induced Reinstatement
In order to determine if CB1 receptor activation plays a role in
stress- or cocaine-induced reinstatement, 24 min prior to forced swim
testing or 30 minutes prior to cocaine injection, the mice were injected
with AM-251 or vehicle. The mice were also injected with AM-251 or
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vehicle 30 minutes before testing in order to determine whether the
AM-251 or vehicle injection could cause reinstatement. All mice
received six treatments (FS+ vehicle, FS+AM-251, cocaine+vehicle,
cocaine+AM-251, AM-251 + vehicle, and vehicle+vehicle) in
counterbalanced order. Mice reached extinction criterion before
retesting.

Reinstatement by the CB1 Receptor Agonist CP 55,940
In order to determine if CB1 receptor activation alone was
sufficient to induced reinstatement, mice were tested for reinstatement
in response to the synthetic CB1 receptor agoninst CP 55,940. Thirty
minutes prior to testing, mice were injected with vehicle or 10, 20 or
40 μg/kg doses of CP 55,940. All mice received all 4 treatments in
counterbalanced order. Mice reached extinction criterion before
retesting.

Reinstatement by CP 55,940 in Combination with BRL44408
Another group of mice were tested for reinstatement by CP
55,940 in combination with a subthreshold dose of the selective alpha2 adrenergic receptor antagonist and pharmacological stressor, BRL44408, in order to determine if cannabinoid receptor activation could
potentiate a pharmacological stressor-induced reinstatement and
whether cannabinoid receptor activation interacted with noradrenergic
mechanisms to induce reinstatement. It has been shown previously
that a sufficient dose of BRL-44408 can induce reinstatement
(Mantsch, et al., 2010). We have found that 5 mg/kg BRL-44408 is a
subthreshold dose. Therefore, 20 μg/kg CP 55,940 and 5 mg/kg BRL44408 were injected i.p. 30 minutes prior to reinstatement testing.

Statistical Data Analyses
Statistical analysis was carried out using SigmaPlot 11 statistical
software (Systat Software, San Jose, CA). Data are expressed as mean
+/- standard error of the mean. The ability of a drug and/or stress
procedure to elicit reinstatement was determined by the difference
between the time spent in the cocaine-paired compartment on the day
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of testing (reinstatement day) and the preceding extinction session
(extinction day). Comparisons between effects of different drugs
and/or stress on reinstatement were also determined. Statistical
significance was determined by two-way repeated measures (RM)
ANOVA with post-hoc multiple comparisons using the Holm-Sidak
method.

Results
Establishment of cocaine-induced conditioned place
preference
Previous studies had determined that 15 mg/kg cocaine dose
was optimal for producing conditioned place preference (Mantsch et
al., 2010). We found significant cocaine-induced conditioned place
preference, defined as an increase in time spent in the cocaine-paired
compartment, was observed in each of the experiments (p≤0.001 for
each experiment). The average number of extinction sessions prior to
the first reinstatement test session was 5.9. Nineteen percent of mice
were not tested for reinstatement since they did not display cocaineinduced conditioned place preference or failed to reach the extinction
criterion.

The effect of AM-251 on stress- and cocaine-induced
reinstatement
Reinstatement was tested in mice which had been conditioned
to cocaine and whose place preference had been extinguished. Both FS
(6 minutes) and cocaine (15 mg/kg, i.p.) produced reinstatement, as
indicated by significant increases in time spent on the cocaine-paired
side compared to the preceding extinction day (p<0.05 Holm-Sidak
following a significant interaction between time (extinction and
reinstatement day) and treatment (F(5,25)=8.142, p<0.001, two-way
RM ANOVA, Figure 1). To determine whether endocannabinoid
signaling was involved in either type of reinstatement, the CB1
receptor antagonist AM-251 was injected before FS and cocaine. AM251 treatment completely blocked the forced swim-induced
reinstatement (no significant difference in the time spent in the
cocaine-paired environment between the extinction and reinstatement
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day within the AM+FS group and a significant effect of treatment
within reinstatement days between FS and AM+FS, p<0.05, Holm
Sidak). AM-251 treatment did not block cocaine-induced reinstatement
(significant effect of time in both Coc and Coc+AM, p<0.05, HolmSidak, no significant difference between reinstatement days with Coc
vs Coc+AM-251). Neither AM-251 nor vehicle produced any
reinstatement when given alone.

Figure 1

The effect of the cannabinoid antagonist AM-251 on forced swim- and

cocaine-induced reinstatement. Data represent the time spent in the cocaine-paired
compartment (mean +/- SEM) during the extinction session prior to reinstatement
testing and after reinstatement testing with forced swim (6 minutes) + vehicle (FS),
FS + AM-251(3 mg/kg, i.p.) (FS+AM), cocaine (15 mg/kg, i.p) + vehicle (Coc),
cocaine + AM-251 (Coc+AM), vehicle, or AM-251. Vehicle and AM-251 were injected
30 minutes prior to reinstatement testing. Coc and FS were administered immediately
prior to reinstatement testing. A significant increase in the time spent in the cocainepaired compartment during reinstatement testing compared to the preceding
extinction session was seen after both FS and cocaine (* =p<0.05, Holm-Sidak
multiple comparison test) but not after AM-251 or vehicle alone. A significant
difference between the time spent in the cocaine-paired compartment on
reinstatement days was seen between the FS and FS+AM251 treatment groups (@ =
p<0.05, Holm-Sidak multiple comparison test) but not between the Coc and the Coc +
AM-251 groups.
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The effect of CP 55,940 on reinstatement of place
preference for cocaine
Mice which had been conditioned to cocaine and whose place
preference had been extinguished were tested with vehicle and three
doses of the CP 55,940 to determine if administration of a cannabinoid
agonist was sufficient to induce reinstatement of place preference
(Figure 2). No reinstatement was observed following 10, 20 or 40
μg/kg administration of CP 55,940 (F(1,21)=0.0875, p=0.776, main
effect of time (extinction vs. reinstatement day), two-way RM ANOVA).

Figure 2

The effect of the cannabinoid agonist CP 55,940 on reinstatement of

extinguished cocaine-induced conditioned place preference. Data represent the time
spent in the cocaine-paired compartment (mean +/- SEM) during the extinction
session prior to reinstatement testing and after reinstatement testing with vehicle
(Veh) or 10, 20 or 40 μg/kg, i.p. CP-55,940, 30 min prior to testing. There were no
significant differences (two way RM ANOVA).
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The involvement of noradrenergic mechanisms in
cannabinoid mediation of cocaine place preference
In order to examine the interaction between cannabinergic and
noradrenergic systems in cocaine reinstatement, another group of
mice which had been conditioned to cocaine and whose place
preference had been extinguished were tested with either 1) vehicle,
2) the alpha-2 adrenergic antagonist BRL-44408 (5 mg/kg, i.p.) or 3)
BRL-44408 (5 mg/kg, i.p.) and CP 55,940 (20 μg/kg). BRL-44408
alone did not induce reinstatement but when combined with the nonreinstating dose of CP 55,940, reinstatement was induced
(F(2,20)=3.499, p<0.05, main effect of treatment, two-way RM
ANOVA followed by Holm-Sidak multiple comparisons, P<0.05, Figure
3).

Figure 3

The effect of combined administration of subthreshold doses of the

cannabinoid agonist CP-55,940 and the alpha-2 adrenergic antagonist BRL-44408 on
reinstatement of extinguished cocaine-induced conditioned place preference. Data
represent the time spent in the cocaine-paired compartment (mean +/- SEM) during
the extinction session prior to reinstatement testing and after reinstatement testing
with vehicles (Veh + Veh), BRL-44408 (5 mg/kg, i.p.) and vehicle (BRL+ Veh), and
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BRL-44408 and CP 55,940 (20 μg/kg, i.p.) (CP+BRL). All injections were administered
30 min prior to reinstatement testing. A significant increase in the time spent in the
cocaine-paired compartment during reinstatement testing compared to the preceding
extinction session was seen after administration of CP and BRL (* =p<0.05, HolmSidak multiple comparison test) but not after BRL or vehicle alone. A significant
difference between the time spent in the cocaine-paired compartment on
reinstatement days was seen between the CP+BRL and the BRL+Veh and the
Veh+Veh treatment groups (@ = p<0.05, Holm-Sidak multiple comparison test).

Discussion
We found that systemic administration of a cannabinoid
antagonist can reverse stress- but not cocaine-induced reinstatement
of cocaine seeking behavior in male C57Bl/6 mice. Cannabinoid
receptors are located in many brain areas involved in stress and
addiction (Herkenham et al., 1990; Mailleux and Vanderhaeghen,
1992). They influence the release of multiple neurotransmitters,
including GAB A, glutamate, norepinephrine and dopamine (LopezMoreno et al., 2008). Given the widespread distribution of cannabinoid
receptors and the multiplicity of neurotransmitter systems with which
the ECS interacts, it is not surprising that the effects of systemic
administration of cannabinoid agonists and antagonists have complex
and even contradictory effects on addictive behavior. In particular,
several studies which used rats to examine the effect of cannabinoids
on cocaine reinstatement using a cocaine self-administration model
found that cannabinoid antagonists block cocaine-induced
reinstatement (De Vries et al., 2001; Filip et al., 2006 ; Xi et al.,
2006) but not stress-induced reinstatement of cocaine seeking
behavior (De Vries et al., 2001). In contrast, Ward et al., (2009) found
that a cannabinoid antagonist did not block cocaine-induced
reinstatement in mice. It is possible that different aspects of
endocannabinoid effects on addiction are being revealed in studies that
use different species, different tests to measure relapse, different
drugs and dosages, and different stress paradigms.
The neurochemical pathways that mediate cocaine- and stressinduced reinstatement are not identical. There is evidence that stressinduced but not cocaine-induced reinstatement involves brain
noradrenergic pathways, in particular noradrenergic systems that
terminate in the bed nucleus of the stria terminalis (BNST) and central
nucleus of the amygdala (Leri et al., 2002). In rat self administration
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models of cocaine reinstatement, treatments that reduce
noradrenergic signaling, either by blocking beta adrenergic receptors
(Leri et al., 2002) or suppressing the release of NE by alpha-2
adrenergic receptor activation (Erb et al 2000), reduce stress-induced
but not cocaine-induced reinstatement of cocaine seeking. In addition,
Mantsch et al., (2010) reported that beta adrenergic receptor
antagonists or drugs that decrease NE release block stress-induced
reinstatement but not cocaine-induced reinstatement using the mouse
conditioned place preference methodology.
It is possible that the ECS plays a role in stress-induced
reinstatement by enhancing the release of NE. We found that systemic
injection of the cannabinoid agonist, CP 55,940 could not induce
reinstatement when injected alone, but did cause reinstatement when
combined with a non-reinstating dose of BRL-44408, an alpha-2A
adrenergic antagonist that causes increased release of NE. Stress has
been shown to alter endocannabinoid concentrations (Patel and Hillard,
2008; Cota, 2008; Hill et al., 2010) and there is significant interaction
between the endocannabinoid and noradrenergic systems. Cannabinoid
receptors are present in the locus coeruleus (LC) and nucleus of the
solitary tract, noradrenergic brainstem nuclei that project to forebrain
areas including the BNST (Herkenham et al., 1991) and
electrophysiological studies have demonstrated that cannabinoid
agonists affect firing rates of neurons in the LC (Mendiguren and
Pineda, 2006; Muntoni et al., 2006). Further, the cannabinoid agonist
WIN 55,212-2 increases c-fos expression in the LC (Patel and Hillard,
2003) and increases forebrain NE release as well as increase indices of
noradrenergic activity (Oropeza et al., 2005; Page et al., 2007; Page
et al., 2008). In addition to possibly acting on brain stem
noradrenergic projection neurons, endocannabinoids could also be
acting within the BNST. CB1 receptors have been localized on
presynaptic excitatory and inhibitory synaptic terminals within the
BNST (Puente et al., 2010) and mRNA for CB1 receptors has been
found in both projection neurons to the BNST as well as in intrinsic
inhibitory neurons (Matsuda et al., 1993). The CB1 receptors within
the BNST have been linked anatomically and functionally to reward
pathways (Massi et al., 2008; Grueter et al., 2006).
Alternative hypotheses regarding the interaction of
cannabinergic and noradrenergic systems are also possible. For
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example, activation of CB1 receptors on GABAergic terminals could
suppress inhibition of neurons downstream from NE release in the
BNST.
The hypothesis that the ECS may serve as a link between stress
and noradrenergic dependent processes has also been proposed for
the consolidation of aversive memories. It is known that noradrenergic
transmission within the basolateral amygdala is critical for stressinduced enhancement of memory consolidation (Roozendaal et al.,
2002; Roozendaal et al., 2004; Roozendaal et al., 2006). Campolongo
et al., (2009) have found that cannabinoid antagonists impair and
cannabinoid agonists enhance stress-induced memory consolidation
and have proposed that stress may act to enhance memory, at least in
part, by stimulating the release of endocannabinoids which then lead
to the release of NE.
Although the results of this study support a possible interaction
between the ECS and noradrenergic systems in stress-induced
reinstatement of cocaine seeking behavior, blockade of swim stressinduced reinstatement by AM-251 may also reflect the interaction of
the ECS with other brain pathways and neurotransmitters. For
example, the ECS has been implicated in the regulation of stress
response by the hypothalamic-pituitary-adrenal axis, as well as the
release of numerous neurotransmitter systems involved in addiction,
including GABA, glutamate, dopamine, serotonin, acetylcholine and
neuropeptides (Lopez-Moreno). The interaction of the ECS with these
systems in stress-induced reinstatement remains to be investigated.
We found that a cannabinoid antagonist blocks stress- but not
cocaine-induced reinstatement of cocaine seeking behavior in mice.
Further, we have found that non-reinstating dose of a cannabinoid
agonist and a non-reinstating dose of an alpha-2 adrenergic
autoreceptor antagonist synergize to produce reinstatement. These
results are consistent with the hypothesis that stress exposure but not
cocaine triggers the endogenous activation of CB1 receptors and that
the ECS interacts with noradrenergic mechanisms to influence stressinduced reinstatement of cocaine-seeking behavior.
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